Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
AnaptysBio, Inc. (NASDAQ: ANAB)
ANAB Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
21.70%
Analyst Rating:
BUY
Analyst Forecast (1yr):
53%
ANAB Stock Analysis
ANAB
PE Ratio:
ANAB
PEG Ratio:
Not Available
ANAB
Forward EPS Growth (12 month):
0.00%
ANAB
PS Ratio:
9.5
ANAB
PSG Ratio:
0.3
ANAB
Forward Revenue Growth (12 month):
30.10%
ANAB Articles
No data was found